diff --git a/journals/2025_02_04.md b/journals/2025_02_04.md
index ff491064..f22d128f 100644
--- a/journals/2025_02_04.md
+++ b/journals/2025_02_04.md
@@ -6,7 +6,9 @@
 	  
 	  En 2017, Mundo Sano se alió con EDCTP para financiar conjuntamente ensayos clínicos de herramientas innovadoras destinadas a enfermedades infecciosas desatendidas. De esta iniciativa surgieron los proyectos STOP 1 y 2, que llevaron a cabo el ensayo clínico (fase 2/3) que ha sustentado el dossier enviado a EMA. También son la base del proyecto STOP2030, del que forma parte Mundo Sano y que busca generar nuevas evidencias sobre seguridad en grandes poblaciones, coste eficiencia y aceptabilidad.
 - Inglés
-	- Last Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive scientific opinion for the fixed-dose combination of albendazole and ivermectin for the treatment of soil-transmitted helminths (STH) and lymphatic filariasis (LF). This marks a significant milestone for a public-private collaboration between more than a dozen partners for over a decade, with
+	- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for the fixed-dose combination of albendazole and ivermectin for the treatment of soil-transmitted helminths (STH) and lymphatic filariasis (LF). This marks a significant milestone for this pharmacological tool and brings it closer to its mass adoption in endemic countries.
+	-
+-
 -
 - # #Tareas
 	- TODO AFINAR el mensaje para enviar a [[EDCTP]]